The expansion of vitamin B3 production will be divided into two projects—an initial 3-cyanopyridine plant followed by a niacinamide niacin production facility. The 3-cyanopyridine plant is expected to be completed by the end of 2009.
“Our production expansion in China is an important step in a global, long-term strategy to meet the increased market demands for vitamin B3,” said Rich Preziotti, chief executive officer of Vertellus Specialties. “In August 2007, we expanded our U.S. pyridine/picolines production units and, in March 2008, we did the same with our pyridine/picolines production capacity in China. Together, these projects provided a 35% increase in capacity for beta picoline, a key raw material input used to produce 3-cyanopyridine and vitamin B3.”
The company has also completed a 25% expansion of its U.S. and European capacity for 3-cyanopyridine. More info: www.vertellus.com